Technology | May 08, 2015

Pie Medical Imaging Upgrades 3mensio Structural Heart Planning Platform

New workflows enable advanced visualization for mitral valve replacement, other structural heart interventions

Pie Medical Imaging, 3mensio Structural Heart, mitral, septal crossing, workflow

May 8, 2015 — Pie Medical Imaging announces its new release of 3mensio Structural Heart, dedicated to planning of structural heart interventions. This new release contains an optimized Mitral workflow and a new Septal Crossing workflow for planning of mitral valve procedures to determine the appropriate access route based on computed tomography (CT) images. These new innovations will be shown at the EuroPCR in Paris, May 19- 22.

More insight on the size and shape of the mitral valve is vital for pre-procedural planning of mitral valve replacement and repair procedures. The Mitral workflow provides advanced visualization and sizing of the mitral annulus and its surrounding structures like the aortic valve and coronary arteries. Also the possible impact on the left ventricular outflow tract (LVOT) clearance of placing a valve can be simulated.
 
The Septal Crossing workflow enables visualization of cardiac structures in a simulated angioview. In this simulated angioview, anatomic relations between the interatrial septum, left atrial appendage (LAA) ostium, mitral annulus and vena cava can be easily determined.

For more information: www.piemedicalimaging.com

Related Content

Gate Bioprosthesis Used in Canada's First Transcatheter Valve Replacement for Tricuspid Regurgitation
News | Heart Valve Technology | February 22, 2018
NaviGate Cardiac Structures Inc. (NCSI)announced that on Feb. 2, 2018, its catheter-guided Gate valved-stent...
Edwards Lifesciences Centera self expanding transcatheter (TAVR) valve has been approved with CE mark for use in Europe.
Feature | Heart Valve Technology | February 15, 2018
February 15, 2018 — Edwards Lifesciences Corp.
Boston Scientific Enters Investment and Acquisition Option Agreement With Millipede
News | Heart Valve Technology | January 24, 2018
Boston Scientific Corp. announced it has closed an investment and entered into an acquisition option agreement with...
Edwards LifeSciences Recalls Sapien 3 Certitude Delivery System
News | Heart Valve Technology | January 11, 2018
The U.S. Food and Drug Administration (FDA) announced that Edwards LifeSciences is recalling its Certitude Delivery...
Videos | Heart Valve Technology | January 04, 2018
Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how hi
Edwards Acquires Harpoon Medical
News | Heart Valve Technology | December 07, 2017
December 7, 2017 — Edwards Lifesciences Corp.
Videos | Heart Valve Technology | November 15, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigato
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients
News | Heart Valve Technology | November 08, 2017
Medtronic plc recently presented new clinical research to support the positive clinical performance of the Evolut...
Videos | Heart Valve Technology | November 08, 2017
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morris
Overlay Init